Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Director departure
|
|
ChemoCentryx, Inc. (CCXI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/31/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Disposed/sold 107,997 shares
@ $0
Disposed/sold 21,076 shares
@ $0
Disposed/sold 5,000 shares
@ $0
Disposed/sold 8,342 options
@ $22.39, valued at
$186.8k
Disposed/sold 4,504 options
@ $10.06, valued at
$45.3k
Disposed/sold 12,287 options
@ $11.6, valued at
$142.5k
Disposed/sold 13,352 options
@ $12.94, valued at
$172.8k
Disposed/sold 12,500 options
@ $13.94, valued at
$174.3k
Disposed/sold 15,723 restricted stock units
@ $0 |
|
| 10/24/2022 |
4
| KANAYA SUSAN M (See Remarks) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Disposed/sold 91,317 shares
@ $0
Disposed/sold 132,717 shares
@ $0
Disposed/sold 71,280 options
@ $29.83, valued at
$2.1M
Disposed/sold 3,920 options
@ $29.83, valued at
$116.9k
Disposed/sold 2,198 options
@ $46.59, valued at
$102.4k
Disposed/sold 19,202 options
@ $46.59, valued at
$894.6k
Disposed/sold 51,518 options
@ $11.02, valued at
$567.7k
Disposed/sold 8,482 options
@ $11.02, valued at
$93.5k
Disposed/sold 10,102 options
@ $10.86, valued at
$109.7k
Disposed/sold 25,000 options
@ $10.86, valued at
$271.5k
Disposed/sold 72,826 options
@ $6.62, valued at
$482.1k
|
|
| 10/24/2022 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Disposed/sold 9,138 shares
@ $0
Disposed/sold 8,342 options
@ $22.39, valued at
$186.8k
Disposed/sold 4,504 options
@ $10.06, valued at
$45.3k
Disposed/sold 12,287 options
@ $11.6, valued at
$142.5k
Disposed/sold 13,352 options
@ $12.94, valued at
$172.8k
Disposed/sold 12,500 options
@ $13.94, valued at
$174.3k
Disposed/sold 15,723 restricted stock units
@ $0 |
|
| 10/24/2022 |
4
| FECZKO JOSEPH M (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Disposed/sold 148,127 shares
@ $0
Disposed/sold 8,342 options
@ $22.39, valued at
$186.8k
Disposed/sold 4,504 options
@ $10.06, valued at
$45.3k
Disposed/sold 12,287 options
@ $11.6, valued at
$142.5k
Disposed/sold 13,352 options
@ $12.94, valued at
$172.8k
Disposed/sold 12,500 options
@ $13.94, valued at
$174.3k
Disposed/sold 15,723 restricted stock units
@ $0 |
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Wheadon David E. (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Disposed/sold 22,274 restricted stock units
@ $0 |
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/20/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/20/2022 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 10/20/2022 |
8-K
| Quarterly results |
| 10/20/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/18/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/07/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/14/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 09/12/2022 |
SC 13G/A
| FMR LLC reports a 0% stake in CHEMOCENTRYX INC |
| 08/31/2022 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 08/18/2022 |
4
| KANAYA SUSAN M (EVP, CFO and Sec.) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 19,898 shares
@ $50.9495, valued at
$1M
Exercised 19,898 options to buy
@ $10.86, valued at
$216.1k
|
|
| 08/09/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/08/2022 |
4
| Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 130,000 shares
@ $50.2441, valued at
$6.5M
Exercised 130,000 options to buy
@ $14.28, valued at
$1.9M
|
|
| 08/08/2022 |
4
| KANAYA SUSAN M (EVP, CFO and Sec.) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 46,298 shares
@ $50.1688, valued at
$2.3M
Exercised 14,583 options to buy
@ $6.23, valued at
$90.9k
Exercised 31,715 options to buy
@ $6.62, valued at
$210k
|
|
| 08/08/2022 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 10,000 shares
@ $50.22, valued at
$502.2k
|
|
| 08/08/2022 |
4
| Cappel Markus J. (Chief Bus. Officer & Treasurer) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Sold 7,564 shares
@ $50.22, valued at
$379.9k
|
|
| 08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/08/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/04/2022 |
8-K
| Quarterly results |
| 07/05/2022 |
8-K
| Quarterly results |
| 06/30/2022 |
4
| Herron Jennifer Lyn (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 17,237 shares
@ $0 |
|
| 06/30/2022 |
3
| Herron Jennifer Lyn (Director) has filed a Form 3 on ChemoCentryx, Inc. |
|
|
|